Literature DB >> 33391936

Type 3 Diabetes Mellitus: A Link Between Alzheimer's Disease and Type 2 Diabetes Mellitus.

Omar Nisar1, Hira Pervez2, Bilvesh Mandalia3, Muhammad Waqas4, Harmandeep Kaur Sra5.   

Abstract

Chronic diseases, as their name suggests, are progressive and can have overlapping features. Similar to this, Alzheimer's disease (AD) and diabetes mellitus (DM) fall into the category of chronic degenerative diseases. The global burden of these two ailments is manifold; hence, it seems important to view the pathophysiologic mechanisms of DM in the worsening of AD. Genetic as well as environmental factors are seen to play a role in the disease pathogenesis. Several genes, metabolic pathways, electrolytes, and dietary habits are seen to hasten brain atrophy. Lying behind this is the accumulation of amyloid precursor and tau - the misfolded proteins - within the brain substance. This mechanism is usually innate to AD itself, but the impact of insulin resistance, disturbing the homeostatic milieu, is seen as a powerful contributing factor aggravating the neuronal loss impairing an individual's memory. Since this neuronal loss is permanent, it may lead to complications as seen with AD. To reach a consensus, we conducted an electronic literature review search using different databases. This aided us in understanding the common aspects between AD and DM on genetic, molecular, cellular levels, as well as the impact of minerals and diet on the disease manifestation. We also found that despite exceptional work, additional efforts are needed to explore the relationship between the two entities. This will help physicians, researchers, and pharmaceuticals to frame remedies targeting the cause and avoid the progression of AD.
Copyright © 2020, Nisar et al.

Entities:  

Keywords:  alzheimer’s dementia; dementia; diabetes type 2; genes; genetics; insulin resistance; single nucleotide polymorphism; type 3 diabetes

Year:  2020        PMID: 33391936      PMCID: PMC7769816          DOI: 10.7759/cureus.11703

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  6 in total

Review 1.  Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis.

Authors:  Angelo Cignarelli; Valentina Annamaria Genchi; Giulia Le Grazie; Irene Caruso; Nicola Marrano; Giuseppina Biondi; Rossella D'Oria; Gian Pio Sorice; Annalisa Natalicchio; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-21       Impact factor: 5.555

Review 2.  Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease: Review and Meta-Analysis.

Authors:  Athanasia Athanasaki; Konstantinos Melanis; Ioanna Tsantzali; Maria Ioanna Stefanou; Sofia Ntymenou; Sotirios G Paraskevas; Theodosis Kalamatianos; Eleni Boutati; Vaia Lambadiari; Konstantinos I Voumvourakis; George Stranjalis; Sotirios Giannopoulos; Georgios Tsivgoulis; George P Paraskevas
Journal:  Biomedicines       Date:  2022-03-27

3.  The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study.

Authors:  Wun-Zhih Siao; Tsung-Kun Lin; Jing-Yang Huang; Chin-Feng Tsai; Gwo-Ping Jong
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

Review 4.  Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis.

Authors:  Nathalie Marissal-Arvy; Marie-Pierre Moisan
Journal:  Metabol Open       Date:  2022-07-31

5.  Relationship between cognitive function in individuals with diabetic foot ulcer and mortality.

Authors:  Yael Sela; Keren Grinberg; Tali Cukierman-Yaffe; Rachel Natovich
Journal:  Diabetol Metab Syndr       Date:  2022-09-19       Impact factor: 5.395

6.  Effect of a Community Gerontology Program on the Control of Metabolic Syndrome in Mexican Older Adults.

Authors:  Víctor Manuel Mendoza-Núñez; Gabriela Pulido-Castillo; Elsa Correa-Muñoz; Juana Rosado-Pérez
Journal:  Healthcare (Basel)       Date:  2022-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.